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In Brief
Estrogen receptor b (ERb) plays a unique
role in endometriotic tissue, where it
interacts with the cytoplasmic apoptotic
machinery and inflammasome complex
to prevent TNF-a-induced cell death and
enhance adhesion and proliferative
activities of endometriotic tissues. This
non-genomic action of ERb has a
predominant role in endometriosis
progression.
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Alterations in estrogen-mediated cellular signaling
play an essential role in the pathogenesis of endome-
triosis. In addition to higher estrogen receptor (ER) b
levels, enhanced ERb activity was detected in endo-
metriotic tissues, and the inhibition of enhanced ERb
activity by an ERb-selective antagonist suppressed
mouse ectopic lesion growth. Notably, gain of ERb
function stimulated the progression of endometri-
osis. As a mechanism to evade endogenous immune
surveillance for cell survival, ERb interacts with
cellular apoptotic machinery in the cytoplasm to
inhibit TNF-a-induced apoptosis. ERb also interacts
with components of the cytoplasmic inflamma-
some to increase interleukin-1b and thus enhance
its cellular adhesion and proliferation properties.
Furthermore, this gain of ERb function enhances
epithelial-mesenchymal transition signaling, thereby
increasing the invasion activity of endometriotic tis-
sues for establishment of ectopic lesions. Collec-
tively, we reveal how endometrial tissue generated
by retrograde menstruation can escape immune sur-
veillance and develop into sustained ectopic lesions
via gain of ERb function.INTRODUCTION
Endometriosis is a medical condition in which endometrial
cells are deposited and grow outside the uterine cavity (Bulun,
2009; Giudice, 2010). Severe symptoms of endometriosis are
typically observed in 6%–10% of reproductive-aged women (Si-
moens et al., 2007). Among patients with endometriosis, approx-
imately 50% have major pelvic pain, and 40%–50% have fertility
problems (Eskenazi and Warner, 1997; Ozkan et al., 2008). In
these patients, endometriosis-associated symptoms negatively
impact their health and quality of life (Moradi et al., 2014).960 Cell 163, 960–974, November 5, 2015 ª2015 Elsevier Inc.To improve the efficiency of endometriosis therapies, it is
important to dissect the unique molecular properties of endo-
metriotic tissues compared with normal endometria. Previous
studies identified several endocrine properties associated with
endometriotic tissues. Altered estrogenic signaling pathways
have been reported in endometriosis pathogenesis (Bulun,
2009). Endometriotic lesions have been reported to contain
higher 17b-estradiol levels than normal endometria due to the
elevated expression of 17b-hydroxysteroid dehydrogenase-1
and aromatase genes compared with normal endometria (Acie´n
et al., 2007; Delvoux et al., 2009). These higher levels of local
17b-estradiol could play a role in the proliferation of endometri-
otic tissues (Zhang et al., 2010). This increased 17b-estradiol
binds and activates estrogen receptors (ERs) in endometriotic
tissues to stimulate estrogen-dependent growth. There are two
different forms of the ER, usually referred to as a and b, each
encoded by a different gene, ESR1 and ESR2, respectively. Prior
studies with ERa/, ERb/mouse models and selective estro-
gen receptor modulators revealed essential roles of both ERa
and ERb in mouse ectopic lesion development (Burney, 2013;
Zhao et al., 2015). However, each ER isoform has a unique
expression pattern between endometriotic tissues and normal
endometrium. In the case of ERa, it is controversial whether
ERa has an endometriotic tissue-specific pattern (Han and
O’Malley, 2014). In contrast to ERa, however, the mRNA level
of ERb is significantly higher in endometriotic tissues than in
normal uterine endometrium (Bulun et al., 2012). Aberrant ERb
levels in endometriotic tissues have been associated with a
distinct epigenomic profile in the ERb genomic locus: a hypome-
thylated promoter of the ERb gene was detected in endometri-
otic tissues compared with normal endometria and correlates
with increased ERb mRNA levels (Xue et al., 2007).
What is the role of ER isoforms in the pathogenesis of endo-
metriosis? Unfortunately, the detailed molecular mechanism
regarding specific contribution of each ER isoform in the
endometriosis progression is not clearly elucidated yet. Only
partial information is available. For examples, ERa/ mouse
with endometriosis revealed that the ESR1 gene is required
for attachment, inflammation, and proliferation of ectopic
lesions (Burns et al., 2012). ERb directly induces Ras-like
Figure 1. Mouse Endometriotic Tissues
Have Elevated Levels of ERb
(A and B) The expression levels of ERb, ERa, PR,
and tubulin in the uteri of sham-treated C57BL/6J
mice and the eutopic endometria (A) and ectopic
lesions (B) of C57BL/6J mice with endometriosis.
(C) IHC and quantitative analyses of ERb levels in
the uteri of sham-treated C57BL/6J mice and
ectopic and eutopic endometria of C57BL/6J mice
with endometriosis.
In all panels, error bars represent ± SD.estrogen-regulated growth-inhibitor gene expression in an
estrogen-dependent manner to enhance the proliferative ac-
tivity of endometriotic tissues (Monsivais et al., 2014). In addi-
tion, ERb directly binds to the ERa promoter region to repress
ERa gene expression, which can lead to a state of progester-
one resistance in the endometriotic tissues by suppressing
ERa-mediated progesterone receptor (PR) expression in en-
dometriotic tissues (Bulun et al., 2012). However, we believe
the complete repertoire of ERb functions to be more compli-
cated because greatly elevated levels of ERb exist in both
nuclear and cytoplasmic locations in endometriotic tissues
(Cheng et al., 2011). We believed a more detailed investigation
should be carried out to fully understand the mechanisms of
ERb action in endometriosis progression.
We propose a cytoplasmic ERB protein network that, in addi-
tion to its genomic functions, promotes endometriosis patho-
genesis in a non-genomic manner. Together with our previouslyCell 163, 960–974,observed SRC-1 coactivator isoform,
these two drivers of endometriotic dis-
ease cooperate to render endometriosis
a therapeutically complex disease.
RESULTS
Mouse Endometriotic Tissues Have
Elevated ERb Levels Similar to
Those in Human Endometriotic
Cells
Human endometriotic cells isolated from
endometriosis patients have higher levels
of ERb, but not ERa, than do normal hu-
man endometrial cells (Han et al., 2012).
Consistent with human endometriotic
cells, both eutopic and ectopic endome-
tria from mice with endometriosis also
hadmarkedly higher ERb levels compared
with the uteri of sham-treated mice (Fig-
ures 1A and 1B). In contrast to ERb, how-
ever, the levels of ERa did not differ in
eutopic endometria but were reduced in
ectopic lesions compared with sham-
treated uteri (Figures 1A and 1B). Levels
of PR were reduced in both ectopic le-
sions and eutopic endometria of mice
with endometriosis compared with the
uteri of sham-treated mice (Figures 1Aand 1B). Immunohistochemistry (IHC) using an ERb antibody
(validation of its specificity in Figure 4B) revealed elevated ERb
levels in the epithelial and stromal compartments of both ectopic
lesions and eutopic endometria compared with those compart-
ments in normal endometrium (Figure 1C). Therefore, the ERb
levels are elevated in endometriotic tissues of mice with endo-
metriosis, similar to the levels observed in human endometriotic
cells.
Endometriotic Tissues Have Enhanced ERb Activity
Compared with Normal Endometria
To determine ERb activity in endometriotic tissues in vivo, we
generated an ERb activity indicator (ERBAI) mouse containing
a modified ERb bacterial artificial chromosome clone that
has a Gal4 DNA-binding domain (DBD) instead of its own DBD
and a hrGFP reporter controlled by the Gal4-upstream activating
sequence (UAS) according to our prior protocol (Han et al., 2009)November 5, 2015 ª2015 Elsevier Inc. 961
Figure 2. Enhanced ERbActivity Is Detected
in the Endometriotic Tissues of Mice with
Endometriosis Compared to Normal Endo-
metria
(A) Generation of a modified ERb bacterial artificial
clone that has a Gal4 DNA-binding domain and
the Gal4-UAS-hrGFP reporter. DY380, bacterial
recombination strain; KanR, kanamycin-resistant
gene; DBD, DNA-binding domain; Gal4-UAS,
Gal4-upstream-activating sequence; FLP, flip-
pase; hrGFP, humanized renilla GFP.
(B) IHC analyses of hrGFP levels in the uteri of
sham-treated ERBAImice and ectopic and eutopic
endometria of ERBAI mice with endometriosis.
(C and D) The quantification of hrGFP levels in the
epithelial (C) and stromal (D) compartments of
each type of endometrium in (B).
In all panels, error bars represent ± SD. See also
Figure S1.(Figures 2A and S1). Therefore, Gal4-ERb binds to Gal4-UAS,
transcribing hrGFP gene expression in response to hormone.
Detailed information regarding the generation and validation of
the ERBAI mouse model is described in the Supplemental Infor-
mation (Figure S1).
To investigate potential alterations in ERb activity in endo-
metriotic tissues during endometriosis progression, endometri-
osis was surgically induced using an ERBAI mouse model
through autotransplantation; to monitor ERb activity, the hrGFP
levels were determined in ectopic and eutopic endometria of
ERBAI mice with endometriosis and in the uteri of sham-treated
ERBAI mice. Elevated hrGFP levels were detected in epithelial
and stromal cells of ectopic and eutopic endometria compared
with those found in the normal uteri of sham-treated ERBAI
mice (Figures 2B– 2D). Therefore, enhanced ERb activities
were detected in the stromal and epithelial compartments of en-
dometriotic tissues compared with normal endometria.962 Cell 163, 960–974, November 5, 2015 ª2015 Elsevier Inc.Enhanced ERb Activity Is Required
for Ectopic Lesion Growth in Mice
with Endometriosis
Although enhanced ERb activity was
detected in endometriotic tissues, it was
not clear whether the enhanced ERb ac-
tivity was required for ectopic lesion
growth. Therefore, PHTPP, an ERb-selec-
tive antagonist (Compton et al., 2004),
was employed to address it. Ectopic
lesions were surgically developed in
ovariectomized C57BL/6J mice con-
taining an Estradiol (E2) pellet. On the
21st day after endometriosis induction,
PHTPP or vehicle was administered
to endometriosis-induced mice (Figure
S2A). Compared with vehicle treatment,
PHTPP treatment significantly sup-
pressed ectopic lesion growth in mice
with endometriosis (Figure 3A). For the
stimulation of ectopic lesion growth, en-
dometriotic tissues recruit immune cells(CD163-positive monocyte/macrophage cells) to enhance im-
mune cell-mediated cytokine signaling (Figure S2B, arrowhead).
However, PHTPP-treated ectopic lesions did not recruit immune
cells comparedwith vehicle-treated ectopic lesions (Figure S2B).
In addition, PHTPP treatment clearly diminished ERb activity in
the epithelial and stromal compartments of ectopic lesions and
the eutopic endometrium of mice with endometriosis compared
with vehicle (Figures 3B and 3C). Collectively, PHTPP inhibits
ERb activity, which leads to endometriotic lesion growth in
mice with endometriosis.
Anti-apoptosis signaling and the acceleration of proliferation
are typical molecular properties associated with the survival of
endometriotic tissues (Pellegrini et al., 2012; Salmassi et al.,
2011). Because endometriotic tissues consist of epithelial and
stromal compartments, signaling communication between these
compartments plays an essential role in endometriotic lesion
progression (Kim et al., 2013). Therefore, functional defects
(legend on next page)
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involving hyperproliferation and anti-apoptosis signaling in either
compartment in endometriotic tissues should impair cellular
processes in the other compartment, ultimately leading to the
suppression of ectopic lesion growth. PHTPP treatment,
compared with vehicle treatment, reduced proliferative activity
as determined by Ki-67 in the epithelial, but not stromal, com-
partments of ectopic lesions in C57BL/6J mice with endometri-
osis (Figure 3D). In the case of apoptosis signaling as determined
by cleaved caspase 8 levels, PHTPP treatment significantly
enhanced apoptotic signaling in both the epithelial and stromal
compartments of ectopic lesions of C57BL/6J mice with endo-
metriosis compared with vehicle treatment (Figure 3E). In addi-
tion to ectopic lesions, PHTPP suppressed proliferation and
anti-apoptosis signaling in the epithelium and inhibited prolifera-
tion in stromal cells in the eutopic endometria of mice with endo-
metriosis (Figures 3F and 3G).
In addition to ERb, PHTPP can inhibit ERa activity in vivo,
although its effects on ERa are minimal (Compton et al., 2004).
To address this issue, the levels of mouse uterine ERa direct
target genes (such as PR, CDKN1A, and ERRFI1) were examined
in ovariectomized mice upon E2 and/or PHTPP treatment.
PHTPP partly reduced the expression of direct ERa target genes
stimulated by E2 (Figures S2C–S2E). Interestingly, a female
mouse fertility assay revealed that PHTPP did not reduce repro-
ductive activity in female mice, whereas an ERa-selective antag-
onist, MPP dihydrochloride, significantly reduced the fertility of
female mice compared with vehicle treatment (Figure S2F).
Therefore, PHTPP does not disrupt the fertility of female mice,
though it partly suppresses uterine ERa activity. In contrast to
the effects of PHTPP, ERB-041 (ERb-specific agonist) treatment
enhanced the mouse ectopic lesion growth compared with
vehicle (Figure S2G).
To address the effects of ERB-041 and PHTPP in human
endometriotic lesion growth, we employed two types of human
endometrial cells: EMosis-CC/TERT cells, which are immortal-
ized human endometriotic epithelial cells isolated from ovarian
endometriomas (Bono et al., 2012), and immortalized human
endometrial stromal cells (iHESCs) (Krikun et al., 2004). For
simplification, EMosis-CC/TERT cells are called immortalized
human endometriotic epithelial cells (iHEECs) hereafter. For
non-invasive bioluminescence imaging analyses of ectopic
lesions in SCID mice, luciferase reporters expressing iHEECs
(iHEECs/Luc) and iHESCs (iHESCs/Luc) were generated using a
lentiviral expression system. To induce endometriosis, a mixture
of epithelial and stromal cells (iHEECs/Luc plus iHESCs/Luc)
was injected into ovariectomized SCID mice with an E2 pellet.
On the 21st day after endometriosis induction, endometriosis-
induced SCID mice were treated with ERB-041 or PHTPP forFigure 3. ERb-Specific Antagonist Regresses Ectopic Lesion Growth
(A) Ectopic lesions isolated from C57BL/6J mice with endometriosis subcutaneo
(B and C) IHC and quantitative analyses of hrGFP levels in ectopic lesions (B) a
treated with vehicle or PHTPP.
(D and E) IHC and quantitative analyses of the expression patterns of Ki-67 (D) a
subcutaneously treated with vehicle or PHTPP.
(F and G) IHC and quantitative analyses of the levels of Ki-67 (F) and cleaved CS
cutaneously treated with vehicle or PHTPP. PLC, percentage of labeled cells; CS
In all panels, error bars represent ± SD. See also Figure S2.
964 Cell 163, 960–974, November 5, 2015 ª2015 Elsevier Inc.another 21 days (Figure S2A). Ectopic lesion image analyses re-
vealed that ERB-041 treatment stimulated human ectopic lesion
growth, whereas PHTPP treatment decreased ectopic lesion
growth in SCID mice (Figure S2H). Moreover, ERBAI mice with
endometriosis also revealed that ERB-041 enhanced ERb activ-
ity in ectopic lesions compared with vehicle treatment (Fig-
ure S2I). Collectively, enhanced ERb activity is required for the
pathogenesis of endometriosis (Table 1).
Loss of ERb Function Suppresses Ectopic Lesion
Growth in Mice with Endometriosis
To directly investigate the loss of ERb function in the pathogen-
esis of endometriosis, endometriosis was surgically induced via
the auto-transplantation of uterine tissue using ERb/ (Krege
et al., 1998) and wild-type (WT) mice. The sizes of the ERb/
ectopic lesions were reduced significantly compared with WT
ectopic lesions (Figure 4A). IHC using an ERb antibody (Saji
et al., 2000) validated the fact that ERb/ ectopic lesions did
not exhibit ERb expression compared with WT ectopic lesions
(Figure 4B).
To investigate how loss of the ERb function impacts ectopic
lesion progression, cell proliferation and apoptotic signals in
each type of ectopic lesion were examined. The reduced levels
of epithelial, but not stromal, proliferation were detected in
ERb/ ectopic lesions compared with WT ectopic lesions (Fig-
ure 4C and Table 1). In contrast to proliferation, however, loss of
ERb functions significantly elevated epithelial, but not stromal,
apoptosis in ERb/ ectopic lesions (Figure 4D and Table 1).
Regarding eutopic endometrium, loss of ERb function did not
impair the proliferation of ERb/ eutopic endometria compared
with WT eutopic endometria during endometriosis progression
(Figure 4E and Table 1). However, apoptosis signaling was
elevated in both compartments of the eutopic endometrium in
the absence of the ERb gene compared with WT eutopic endo-
metrium (Figure 4F and Table 1).
Gain of ERb Function Stimulates Ectopic Lesion Growth
in Mice with Endometriosis
To mimic ERb elevation in human and mouse endometriotic tis-
sues, an endometrium-specific ERb-overexpressing mouse
model was generated and validated (Figure S3). For simplifica-
tion, ROSALSL:ERb/+ monogenic mice, which do not express
exogenous ERb, and endometrium-specific ERb-overexpress-
ing (ROSALSL:ERb/+:PRCRE/+) bigenic mice are hereafter referred
to as control and ERb:OE mice, respectively (Figure S3A).
To determine whether endometrium-specific ERb overexpres-
sion impacts ectopic lesion growth, endometriosis was surgi-
cally induced by auto-transplantation using ovariectomizedusly treated with vehicle or PHTPP.
nd eutopic endometria (C) of ERBAI mice with endometriosis subcutaneously
nd cleaved CSP8 (E) in ectopic lesions of C57BL/6J mice with endometriosis
P8 (G) in the eutopic endometria of C57BL/6J mice with endometriosis sub-
P8, caspase 8.
Table 1. Proliferation and Apoptosis in Ectopic Lesions and
Eutopic Endometria of PHTPP-Treated, ERb/, and ERb:OEMice
with Endometriosis
Cellular
Process
Type of
Endometrium Compartment PHTPP ERB/ ERB:OE
Proliferative
activity
ectopic
lesions
epithelium   +
stromal 0 0 +
eutopic
endometrium
epithelium  0 +
stromal  0 +
Apoptosis
signaling
ectopic
lesions
epithelium + + 
stromal + 0 
eutopic
endometrium
epithelium + + 0
Stromal 0 + 0
Ectopic lesion volume   +
+: increased, 0: no change,: decreased compared to vehicle treatment,
WT, or control mice.control and ERb:OE mice containing E2 pellets. ERb:OE ectopic
lesions hadmuch larger volumes than did control ectopic lesions
in mice with endometriosis (Figure 5A). Exogenous Flag/Myc-
tagged ERb expression and elevated levels of total ERb were
determined in ERb:OE ectopic lesions compared with control
ectopic lesions (Figures 5B and S3). Thus, elevated ERb levels
in ectopic lesions enhanced ectopic lesion growth. The overex-
pression of nuclear receptors can induce ligand-independent
effects (Weigel and Zhang, 1998). However, neither control nor
ERb:OE endometrial tissue fragments successfully developed
into ectopic lesions in ovariectomized mice without the admin-
istration of an E2 pellet (Figure S3F). Therefore, gain-of-ERb-
function-mediated stimulation of ectopic lesion growth is an
estrogen-dependent process.
The proliferative activity was significantly elevated in both the
epithelial and stromal compartments of ERb:OE ectopic lesions
compared with control ectopic lesions (Figure 5C and Table 1).
However, apoptosis was significantly reduced in both the epithe-
lial and stromal compartments of ERb:OE ectopic lesions
compared with control lesions (Figure 5D and Table 1).
In addition to ectopic lesions, both the epithelial and stromal
compartments of the ERb:OE eutopic endometrium demon-
strated enhanced proliferative activity compared with control
eutopic endometrium (Figure 5E and Table 1). However, no alter-
ation in apoptosis signaling was detected in ERb:OE eutopic
endometrium compared with control eutopic endometrium (Fig-
ure 5F and Table 1). Thus, the eutopic endometria of endometri-
osis patients appear primarily to be in a hyperproliferative state
due to elevated ERb levels. Notably, breeding trials designed
to assess mating success revealed that ERb:OE mice were
infertile compared with control mice (Figure S3G). Moreover,
ERb-overexpressing iHESCs lose their decidualization response
because, as compared with parental iHESCs, the induction of
decidual cell marker genes, such as insulin-like growth factor-
binding protein 1 and prolactin, was significantly reduced upon
estradiol-medroxyprogesterone-cAMP treatment (Figures 5G–
5I). Therefore, endometriosis-associated ERb overexpression
in eutopic endometrium might impair the decidualization pro-
cess in women with endometriosis, leading to infertility.ERb Interacts with the Cytoplasmic Apoptosis and
Inflammasome Machinery in Ectopic Lesions to
Enhance Ectopic Lesion Survival
To further dissect the molecular mechanisms of ERb in endo-
metriosis progression, Flag-tagged ERb-containing protein
complexes were immunoprecipitated (IPed) from the eutopic
endometria of ERb:OEmicewith endometriosis using a Flag anti-
body. In IP/Mass analyses, a primary consideration is to sepa-
rate out proteins that non-specifically interact with beads from
the list of proteins that are associated with the target protein.
For this purpose, we employed control mice that had the same
genetic background as ERb:OE mice and had extremely low
levels of Flag-tagged exogenous ERb compared with ERb:OE
mice (Figure 6A). Therefore, proteins co-IPed with the Flag anti-
body from endometriotic tissues of control mice are considered
as non-specific bead-binding proteins. To specifically identify
ERb-interacting proteins, proteins IPed from the eutopic endo-
metria of control mice were removed from the proteins that
IPed from the eutopic endometria of ERb:OE mice. Gene
Ontology analyses with endometriotic tissue-specific ERb-inter-
acting proteins revealed that large numbers of proteins involved
in inflammation and apoptosis signaling were specifically
co-IPed with ERb from ERb:OE eutopic endometrium (Figures
S4A and S4B). To validate these interactions in ectopic lesions,
the ERb complex was isolated from control and ERb:OE ectopic
lesions using a Flag antibody, and ERb-interacting proteins
were analyzed further by western blot analyses (Figure 6A).
Western blot analyses revealed that only a very weak Flag-ERb
signal was detected in control ectopic lesions that developed
in ROSALSL:ERb/+ monogenic mice; this small amount is likely
attributable to the leaky expression of exogenous ERb in the
ROSALSL:ERb/+ monogenic mouse (Figure 6A).
Apoptosis signal-regulating kinase 1 (ASK-1) was found to
interact prominently with ERb in ectopic lesions (Figure 6A).
ASK-1 is a component of tumor necrosis factor alpha (TNF-a)-
induced apoptosis complex I, and its activation is required for
TNF-a-induced apoptosis in multiple cell types (Tobiume et al.,
2001). In addition to ASK-1, serine/threonine kinase receptor-
associated protein (STRAP) and 14-3-3 were also specifically
co-IPed with ERb from the ERb:OE ectopic lesions, but not
from control ectopic lesions (Figure 6A). To prevent TNF-
a-induced apoptosis, STRAP and 14-3-3 proteins interact with
ASK-1 to disrupt associations between TNF receptor-associ-
ated factor 2 (TRAF2) and ASK-1 upon TNF-a stimulation (Hatai
et al., 2000). These data imply that ERb may induce ASK-1/
STRAP/14-3-3 complex formation to prevent the activation of
TNF-a/ASK-1-mediated apoptosis in endometriotic tissues. To
validate this hypothesis, the levels of ASK-1 phosphorylation at
Thr845 were determined for each type of ectopic lesion because
ASK-1 phosphorylation at Thr845 is associated with ASK-1 acti-
vation to enhance TNF-a-induced apoptosis (Tobiume et al.,
2002). The phospho-Thr845 ASK-1 levels were significantly
reduced in ERb:OE ectopic lesions compared with control
ectopic lesions without alternation of total ASK-1 levels (Figures
6B–6D). In contrast, the levels of total ASK-1 and phospho-
ASK-1 were significantly elevated in ERb/ ectopic lesions
compared with WT ectopic lesions (Figures S5A– S5C). Collec-
tively, ERb induced ASK-1/STRAP/14-3-3 complex formationCell 163, 960–974, November 5, 2015 ª2015 Elsevier Inc. 965
(legend on next page)
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to prevent ASK-1 activation in ectopic lesions, thereby pro-
moting ectopic lesion survival. TNF-a-induced ASK-1 activation
also increases mitochondrial cytochrome c levels to activate
caspase 9 (Hatai et al., 2000). The cytochrome c levels in ERb:OE
ectopic lesions were significantly lower than those in control
ectopic lesions (Figure 6E). Therefore, the gain of ERb function
prevented the TNF-a/ASK-1/cytochrome c signaling pathway
in ectopic lesions to promote lesion survival.
After the initiation of TNF-a-induced apoptosis by apoptosis
complex I, the tumor necrosis factor receptor (TNFR) 1-associ-
ated death domain (TRADD) protein, a component of complex I,
is shuttled from TNFR to the cytoplasm and then interacts
with the Fas-associated via death domain (FADD) protein and
caspase 8 to generate apoptosis complex II to amplify TNF-
a-induced apoptosis (Micheau and Tschopp, 2003). The endo-
metriotic 70 kDa SRC-1 isoform also interacts with caspase 8
to inhibit caspase 8 activation in ectopic lesions to promote their
survival (Han et al., 2012). Interestingly, we also found that ERb
interacted with caspase 8 and this SRC-1 isoform in ectopic
lesions (Figures 6A and S4C). Moreover, ERb:OE ectopic lesions
contained significantly reduced levels of cleaved caspase 8
compared with control ectopic lesions (Figure 5D). Therefore,
we suggest that ERb also interacts with caspase 8 along with
the SRC-1 isoform; this combined interaction strongly inhibits
caspase 8 activation in ectopic lesions to effectively prevent
activation of TNF-a-induced apoptosis complex II in ectopic
lesions. However, this SRC-1 isoform/ERb/caspase 8 complex
did not interact with components of TNF-a-induced apoptosis
complex I and the apoptosome in ectopic lesions (Figure S4D).
To validate synergism between the SRC-1 isoform and ERb for
the progression of endometriosis, a combination of Gossypol
that reduces the transcriptional activity and stability of SRC-1
(Wang et al., 2011) and PHTPP was employed to suppress
ectopic lesion growth in mice with endometriosis. This combina-
tion of Gossypol and PHTPP treatment significantly reduced
ectopic lesion growth compared with individual treatments (Fig-
ures 6F and 6G). Therefore, cooperative interactions between
the ERb and SRC-1 isoforms effectively appear to drive the path-
ogenesis of endometriosis.
The cytochrome c effectively induces the formation of the
apoptosome, which consists of caspase 9 and apoptotic pepti-
dase-activating factor 1 (APAF-1), to activate caspase 9 (Bratton
and Salvesen, 2010). In ERb:OE ectopic lesions, the interaction
of caspase 9 and APAF-1 was not detected (Figures 6H and
S5D). The cleaved caspase 9 levels were significantly reduced
in ERb:OE ectopic lesions compared with those in control
ectopic lesions (Figure 6I). In ERb/ ectopic lesions, however,
the interaction of caspase 9 and APAF-1 was detected (Fig-
ure S5D). These data suggest that ERb prevented TNF-
a-induced apoptosome formation in endometriotic cells by
disrupting the interaction of caspase 9 and APAF-1 through aFigure 4. The Loss of ERb Function Prevents Ectopic Lesion Growth
(A) Ectopic lesions isolated from C57BL/6J (WT) and ERb/ mice with endomet
(B) IHC analyses and quantification of the ERb levels in ectopic lesions isolated
(C–F) IHC and quantitative analyses of Ki-67 (C and E) and cleaved CSP8 (D and
eutopic endometria (E and F) of WT and ERb/ mice with endometriosis.
In all panels, error bars represent ± SD.competitive ERb interaction with caspase 9. Collectively, ERb
synergistically inhibited the activation of apoptosis complex I
and complex II and apoptosome formation in ectopic lesions
to effectively prevent TNF-a-induced apoptosis in endometriotic
tissues for ectopic lesions survival.
Caspase 1 and the NLR family pyrin domain-containing 3
(NALP3) were also co-IPed with ERb from ERb:OE ectopic
lesions (Figures 6H and S4B). Both caspase 1 and NALP3 are
components of the inflammasome, which is involved in thematu-
ration of IL-1b formation from pro-IL-1b (Willingham et al., 2009).
Interestingly, the NALP3-mediated inflammasome has an essen-
tial role in endometriosis progression because NALP3/
ectopic lesion volume was significantly reduced compared
with WT ectopic lesions of mice with endometriosis (Figure 6J).
IL-1b is a key cytokine involved in both the adhesion and prolif-
eration of endometrial cells (Cao et al., 2005; Sillem et al., 1999).
ERb:OE ectopic lesions had higher IL-1b levels than control
ectopic lesions because cleaved caspase 1 levels were highly
elevated in ERb:OE ectopic lesions compared with controls
(Figures 6K and 6L). However, cleaved caspase 1 and IL-1b
levels were reduced in ERb/ ectopic lesions compared with
WT lesions of mice with endometriosis (Figure S5A). Therefore,
the combinational interactions of ERb with caspase 1 and
NALP3, the activation of caspase 1, and the elevation of IL-1b
levels in ectopic lesions supported our conclusion that ERb
also enhances inflammasome activity in ectopic lesions for their
survival.
This Flag-ERb-interacting protein network may not accurately
recapitulate the endogenous ERb-interacting protein network in
endometriotic tissues because this network was generated by
overexpressed exogenous ERb. To further address this issue,
ERb complexes were isolated from ectopic lesions of C57BL/
6J mice with endometriosis because these ectopic lesions had
elevated endogenous ERb levels (Figure 1B). The SRC-1 iso-
form, caspase 8, caspase 9, caspase 1, and ASK-1 were also
co-IPed with endogenous ERb from ectopic lesions similar
to exogenous Flag-ERb, though the IP efficiency of ERb anti-
body (SC-8794, Santa Cruz) is low (Figure S4E). Therefore, we
concluded that the overexpressed ERb complex is similar to
the endogenous ERb complex in endometriotic tissues.
Gain of ERb Function Prevents TNF-a-Induced
Apoptosis and Enhances Proliferation, Invasion, and
Adhesion Activities of Immortalized Human
Endometriotic Epithelial Cells
To investigate the functions of ERb and the ERb/SRC-1 isoform
complex, iHEECs stably expressing ERb (iHEECs/ERb) and the
SRC-1 isoform (iHEECs/SRC-1Iso) were generated separately
and together (iHEECs/ERb/SRC-1Iso) (Figure 7A, in bottom).
TNF-a treatment increased the levels of cleaved caspase 8
and cleaved caspase 3 in control iHEECs compared with vehicleriosis.
from WT and ERb/ mice with endometriosis.
F) in the epithelial and stromal compartments of ectopic lesions (C and D) and
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Figure 5. The Gain of ERb Function Stimu-
lates Ectopic Lesion Growth
(A) Ectopic lesions isolated from control and
ERb:OE mice with endometriosis.
(B) Exogenous Flag/Myc-tagged human ERb (F/M-
hERb) protein levels in the eutopic endometria of
control and ERb:OE mice with endometriosis.
mERb, endogenous mouse ERb.
(C–F) IHC and quantitative analyses of Ki-67 (C and
E) and cleaved CSP8 (D and F) in the epithelial and
stromal compartments of ectopic lesions (C and D)
and eutopic endometria (E and F) of control and
ERb:OE mice with endometriosis. Higher magnifi-
cation views of the boxed regions are shown.
(G) Exogenous Myc-tagged human ERb (Myc-
hERb) protein levels in iHESCs/ERb as determined
with a Myc antibody.
(H and I) The quantification of relative changes in
the mRNA levels of decidualization marker genes,
IGFBP1 (H) and PRL (I), in iHESCs (Control) and
iHESCs/ERb (ERbOE) upon estrogen/medrox-
yprogesterone/db-cAMP (ECP) treatment on the
indicated day.
In all panels, error bars represent ± SD. See also
Figures S3.
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Figure 6. ERb Interacts with TNF-a-Induced Apoptosis Complexes and the Inflammasome in Endometriotic Tissues of Mice with
Endometriosis
(A) Flag-ERb complexes IPed with a Flag antibody from ectopic lesions of control and ERb:OE mice with endometriosis followed by western blotting (WB) with
antibodies against ASK-1, STRAP, 14-3-3, CSP8, SRC-1, Flag, and tubulin.
(B and C) IHC and quantitative analyses of phospho-Thr845-ASK-1 (P-ASK-1) (B) and total ASK-1 (C) in control and ERb:OE ectopic lesions.
(D) Western blot analyses of phospho-Thr845-ASK-1 (P-ASK-1), total ASK-1, ERb, and tubulin in control and ERb:OE ectopic lesions.
(E) IHC and quantitative analyses of cytochrome c levels in control and ERb:OE ectopic lesions.
(F and G) Regression of ectopic lesion growth in endometriosis-induced C57BL/6J mice subcutaneously treated with Gossypol, PHTPP, or their combination
compared to vehicle (F). Quantification of ectopic lesion volume in (F) is shown in the graph (G).
(H) The IPed Flag-ERb complex from ERb:OE ectopic lesions with a Flag antibody or IgG followed by western blotting with antibodies against Flag, CSP 9,
APAF-1, CSP1, and NALP3. *, non-specific protein.
(I) IHC and quantitative analyses of cleaved CSP9 levels in control and ERb:OE ectopic lesions. Higher-magnification views of the boxed regions are shown.
(J) Ectopic lesions isolated from C57BL/6J (WT) and NALP3/ mice with endometriosis.
(legend continued on next page)
Cell 163, 960–974, November 5, 2015 ª2015 Elsevier Inc. 969
(Figure 7A). However, TNF-a treatment did not enhance the
levels of the above apoptosis markers in iHEECs/ERb, in
iHEECs/SRC-1Iso, or in the combined iHEECs/SRC-1Iso/ERb
(Figure 7A). Therefore, ERb and ERb/SRC-1 isoform complex
effectively prevented TNF-a-induced apoptosis. The gain of
ERb, but not the SRC-1 isoform, function elevated the IL-1b
levels in iHEECs in the presence or absence of TNF-a treatment
(Figure 7A). These data were also generated via the artificial
overexpression of ERb. To support that gain of ERb function is
not artificial, primary human endometriotic stromal cells isolated
from human endometriosis patients were employed because
these cells also had elevated levels of endogenous ERb
compared with normal human endometrial stromal cells (Fig-
ure S4F). Primary human endometriotic stromal cells also have
elevated levels of IL-1B and anti-apoptosis signaling upon
TNF-a treatment compared with normal endometrial stromal
cells (Figure S4G). Therefore, ERb plays a critical role in anti-
apoptosis signaling and inflammasome activation in ectopic
lesions. In addition, ERb enhanced the cell adhesion and prolif-
erative activities of iHEECs compared with control cells in the
presence of TNF-a (Figures 7A and 7B). Therefore, it is likely
that the increased IL-1b observed with elevated ERb induces
adhesion and proliferation activities of endometrial tissue frag-
ments in the peritoneal area of endometriosis patients to initiate
ectopic lesion development. In addition to IL-1b, the levels
of several cytokines (such as MIP-2, IL-16, MIP-1a, MCP-5,
TREM-1, and BLC) were significantly elevated in ERB:OE
ectopic lesions compared with control ectopic lesions (Figures
S6A and S6C). Previous studies also revealed that levels of these
cytokines are elevated in the peritoneal fluid of women with
endometriosis (Ahn et al., 2015). In contrast, some cytokine
levels (MIG, M-CSF, TNF-a, KC, and IP-10) were reduced in
ERB:OE ectopic lesions compared to control ectopic lesions
(Figures S6A and S6B). Collectively, the gain of ERb function
broadly alters the cytokine milieu in ectopic lesions in concert
with promotion of endometriotic lesion growth. Consistent with
SRC-1 isoform, ERb also increased the expression of EMT
markers, such as Slug and Snail, and enhanced invasion activity
in iHEECs (Figures 7A and 7C). Therefore, the increased EMT
and invasion activity of ectopic lesions again occurs through
the effective cooperation of the ERb and SRC-1 isoforms. How-
ever, vascular endothelial growth factor (VEGF) levels were not
changed in ERb:OE ectopic lesions and iHEECs/ERb compared
with their controls (Figures S6D and S6E). Therefore, the angio-
genesis of ectopic lesions is not regulated by ERb.
To further support the gain of ERb function in human
ectopic lesion development, iHEECs/Luc, iHEECs/ERb/Luc,
and iHESCs/Luc were employed for non-invasive biolumines-
cence imaging analysis of ectopic lesion growth in SCID mice.
To induce endometriosis, a mixture of iHESCs/Luc plus
iHEECs/ERb/Luc was injected into ovariectomized SCID mice
with an E2 pellet. For controls, a mixture of iHESCs/Luc and
iHEECs/Luc was injected. Bioluminescence image analysis on(K) IHC and quantitative analyses of IL-1b levels in control and ERb:OE ectopic l
(L) Western blot analyses of levels of IL-1b, CSP1, Flag-tagged ERb, and tubulin (a
surgically induced endometriosis.
In all panels, error bars represent ± SD. See also Figures S4 and S5.
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trial cells for each group were injected into recipient SCID
mice (Figure 7D). Comparative bioluminescent analysis on the
21st day after injection revealed that human ectopic lesions
with ERb overexpression exhibited stronger bioluminescent
activity comparedwith control ectopic lesions (Figure 7E). There-
fore, ERb enhanced the in vivo survival rate of human endome-
triotic cells and promoted their development into human ectopic
lesions in SCID mice.
In addition to ERb, ERa plays an essential role in the pathogen-
esis of endometriosis in the mouse model (Burns et al., 2012). To
determine the functional difference between ERa and ERb in
endometriosis progression, iHEECs expressing Myc-tagged hu-
man ERa genes (iHEECs/ERa) were generated (Figure S7A). In
contrast to iHEECs/ERb, however, gain of ERa function did not
prevent TNF-a-induced apoptosis signaling and did not induce
IL-1b expression, proliferative activity, or expression of EMT
markers (Slug and Snail) and VEGF in iHEECs/ERa compared
with parental iHEECs upon TNF-a treatment (Figure S7A).
Unlike ERb, therefore, ERa is not involved directly in the
evasion of immune surveillance or in the invasion and IL-1b-me-
diated proliferation of ectopic lesions. For the combination of
ERa and ERb, ERa did not interfere with ERb-mediated anti-
apoptotic activity in iHEECs upon TNF-a treatment (Figure S7B).
In fact, ERa inhibited ERb-mediated IL-1b production (Fig-
ure S7B). Therefore, ERamight be involved in the negative regu-
lation of ERb-mediated inflammasome activation.
Taken together, the gain of ERb and SRC-1 isoform function in
endometrial fragments generated by retrograde menstruation
prevents TNF-a-induced apoptosis complex activity to evade
immune surveillance. After evasion, ERb interacts with the in-
flammasome complex to induce IL-1b in endometrial fragments
that have evaded immune surveillance to facilitate attachment to
and growth at target sites (Figure 7F). In addition, ERb also in-
duces EMT and invasion activity in cooperation with the SRC-1
isoform to establish endometriotic lesions (Figure 7F).
DISCUSSION
ERb Has Non-genomic Action for Anti-apoptosis and
Inflammasome Activation
The physiological effects of estrogen are mediated by estradiol
binding to one of the ER isoforms, ERa and ERb. Estrogen-
liganded ER isoform then binds to specific DNA sequences
called estrogen response elements. Interestingly, phenotype
analyses of ERa/, ERb/, ERa/:ERb/ bigenic mouse
models have revealed that ER isoforms have overlapping but
also unique roles in estrogen-dependent action in vivo (Walker
and Korach, 2004). For their unique function, ERa and ERb
have different transcriptional activities in certain ligand, cell-
type, and promoter contexts. In the case of endometriotic tis-
sues, both ER isoforms are expressed in endometriotic tissues
and required for endometriotic lesion growth. The gain of ERbesions.
s a protein loading control) in ectopic lesions of control and ERb:OE mice with
Figure 7. Gain of ERb Function Prevents TNF-
a-Induced Apoptosis Signaling but Stimulates Pro-
liferation, Adhesion, and Invasion Activities of Human
Endometriotic Cells
(A) Levels of cleaved CSP8, cleaved CSP3, IL-1b, Ki67, Slug,
Snail, and SRC-1 isoform (determined by a Flag antibody); ERb
(determined using a Myc antibody); and tubulin in iHEECs
(Control), iHEECs/SRC-1Iso (SRC-1ISO), iHEECs/ERb (ERb),
or iHEECs/SRC-1Iso/ERb (SRC-1ISO+ERb) upon 50 ng/ml
TNF-a plus 10 mg/ml cycloheximide treatment for 0 and 8 hr.
(B) Cell-adhesion activities of paternal iHEECs (Control) and
iHEECs/ERb (ERb) against various extracellular matrices in the
presence of 50 ng/ml TNF-a.
(C) Invasion activities of iHEECs (Control) and iHEECs/ERb
(ERb) for 2 days using a Transwell plate assay. The amounts of
invasive cells in each group were determined using a crystal
violet staining protocol and are shown in the graph.
(D and E) Bioluminescence and quantitative analyses of
iHEECs/Luc (Control) and iHEECs/ERb/Luc (ERb) in SCIDmice
at 0 (D) and 21 (E) days after the induction of endometriosis.
(F) Working model for the non-genomic action of ERb in
endometriosis progression.
In all panels, error bars represent ± SD. See also Figures S6
and S7.
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function study revealed that ERb prevents apoptosis singling
and enhances adhesion, invasion, proliferation, inflammasome
activity, and inflammation signaling in ectopic lesions for their
growth. The study with ERa(/) mice with endometriosis re-
vealed that ERa drives proliferation, adhesion, and angiogenesis
and also modulates inflammation signaling in ectopic lesions
(Burns et al., 2012). To establish endometriotic lesions, collec-
tively, both ERa and ERb might synergistically contribute the
regulation of proliferation, adhesion, and inflammation signaling
in ectopic lesions. However, ERa mainly drives angiogenesis,
and ERb has a predominant role in anti-apoptosis and activa-
tion of inflammasome and invasion in ectopic lesions for their
survival.
Based on a retrograde menstruation model for endometriosis
(Hughesdon, 1958), endometrial tissue and erythrocytes are
shed through the fallopian tubes into the peritoneal cavity during
menses. In healthy women, refluxed endometrial fragments that
appear during retrograde menstruation are cleared by inflam-
matory mediated cell-death signaling, such as caspase-1-medi-
ated pyroptosis (Miao et al., 2011). However, endometriosis
patients have an immunity that prevents them from clearing
the refluxed endometrial fragments and then potentiates the
development and severity of endometriosis. For survival, endo-
metrial tissue fragments must evade the immune surveillance
system, particularly peritoneal macrophages (Nasu et al.,
2009). During the early steps of evasion from the immune sur-
veillance system, ERb generates a cytoplasmic protein network
to rapidly prevent TNF-b-mediated apoptosis by inactivating
TNF-a-induced apoptosis complex I and II and the apopto-
some. We believe that a key synergism exists between ERb
and the SRC-1 isoform during this evasion of the immune sur-
veillance system because the SRC-1 isoform also prevents
TNF-a-induced apoptosis in ectopic lesions. Our combined ob-
servations lead us to propose that ERb and the SRC-1 isoform
act cooperatively together to affect a potent anti-apoptotic state
in endometriotic tissues.
The formation of the inflammasome and the activity of cas-
pase 1 determine the balance between pathogen resolution
and disease pathology. How is the inflammasome involved in
the pathogenesis of endometriosis? The NALP3 gene has an
essential role in endometriosis progression because NALP3/
mice have a defect in ectopic lesion growth under endometri-
osis. ERb involves in upregulation of the NALP3 inflammasome
in hepatocellular carcinoma cells upon estrogen stimulation
even though the interaction of ERb with NALP3 is not clearly
demonstrated (Wei et al., 2015). Here, we revealed that ERb in-
teracts with inflammasome components and enhances inflam-
masome activity through the activation of caspase 1 activity.
Activation of the inflammasome results in highly elevated IL-1b
levels in endometriotic tissues compared with normal endome-
trium, and enhanced IL-1b signaling can influence the adhesion
activity of endometriotic tissues and proliferative activities of
human endometrial cells.
The Gain of ERb Function May Lead to Female Infertility
One of the primary symptoms associated with endometriosis is
dysfunction of the normal endometrium, leading to endometri-
osis-associated infertility (Holoch and Lessey, 2010). In addi-972 Cell 163, 960–974, November 5, 2015 ª2015 Elsevier Inc.tion to ectopic lesions, we found that eutopic endometrium
demonstrated elevated levels of ERb compared with normal
endometrium. We believe that ERb overexpression could in-
crease endometriosis-associated infertility by preventing the
decidualization response in the stromal compartment of eu-
topic endometrium. Thus, targeting ERb could have dual
potential benefits in patients with endometriosis: regression
of ectopic lesion growth and enhancement of fecundity of
women with endometriosis.
A Combination Therapy using Antagonists of ERb and
the SRC-1 Isoform Represents a Proof-of-Principle for
the Next Generation of Endometriosis Therapy
Inhibitors of estrogen signaling and estrogen synthesis as well as
inflammatory inhibitors (COX-2 inhibitors) have been employed,
given the dependence on estrogen and the inflammatory
response of ectopic lesions. However, these treatments can be
associated with undesirable side effects. In addition to substan-
tiating an infertile state in young women, long-term estrogen
deficiency therapies can have harmful side effects on other es-
trogen target tissues, such as the brain and bone (Shah et al.,
1987; Vanderschueren et al., 1997). Therefore, a greater choice
of alternate therapies that more specifically target endometriotic
causal modes is needed.
Our observations proposed that the targeting ERb activity
should increase the specificity and efficiency of endometriosis
treatment and could be an alternative combinational approach
for endometriosis treatment in lieu of current estrogen-defi-
ciency therapy. As a proof-of-principle, the application of an
ERb-selective antagonist, such as PHTPP, significantly sup-
pressed ectopic lesion growth by inhibiting ERb activity in
ectopic lesions of mice with endometriosis without side effects
on fertility. The minimal inhibitory effects of PHTPP against uter-
ine ERa could also be another advantage to minimize side
effects. We note that a previous study stated that ERB-041, an
ERb-specific agonist, caused regression of ectopic lesion
growth in an endometriosis animal model system (Harris et al.,
2005). The reason for this discrepancy could potentially be
related to differential ERb expression in ectopic lesions. The
expression of ERb was not detected in human ectopic lesions
that developed in athymic nude mice in Harris’ study. PHTPP
treatment demonstrated certain differential effects in endometri-
otic tissues compared with ERb knockout tissues. For example,
proliferation of eutopic endometrium and apoptosis in the stro-
mal compartment of ectopic and eutopic endometrium were
differentially regulated between them. This differential regulation
might be attributable to the differences between pharmacolog-
ical inhibition and genetic knockout.
Collectively, we propose that the SRC-1 isoform/ERb com-
plex could be a next-generation endometriosis therapeutic
target with reduced side effects compared to current endome-
triosis treatment because (1) ERb and the SRC-1 isoform show
endometriotic tissue-specific expression but have little expres-
sion in normal endometrium; (2) both play an essential role in the
early stages of endometriosis pathogenesis; and (3) targeting
both of these drivers allows the marked suppression of ectopic
lesion growth in animals compared with either individual agent
alone.
EXPERIMENTAL PROCEDURES
Mouse Information
Five-week-old normal (C57BL/6J), ERb/ (B6;129P2-Esr2tm1Unc/J),
NALP3/ (B6.129S6-Nlrp3tm1Bhk /J), and SCID (NOD.CB17-Prkdcscid/J)
mice were purchased from Jackson Laboratory. ROSALSL:ERb/+ and ERBAI
mice were generated. The ROSALSL:ERb/+:PRCre/+ mice were generated by
crossing ROSALSL:ERb/+ with PRCre/+ mice (Soyal et al., 2005). All animal care
was controlled by the ethical regulations approved by the Institutional Animal
Care and Use Committee at Baylor College of Medicine.
Immortalized Human Endometrial Cells
iHESCs and EMosis-CC/TERT1 (immortalized human endometriotic epithelial
cells) were employed and confirmed by short tandem repeat profiling; these
cells were not contaminated with mycoplasma.
Surgically Induced Endometriosis
Endometriosis in mice was surgically induced under aseptic conditions under
anesthesia. Details on surgically induced endometriosis are found in the Sup-
plemental Experimental Procedures.
Generation of ERBAI and ERb:OE Mice
Details on thesemice are found in the Supplemental Experimental Procedures.
In Vivo Analysis of Human Ectopic Lesion Growth in SCID Mice
The bioluminescence images of human ectopic lesions developed with
iHESCs/Luc plus iHEECs/Luc (or iHEECs/ERb/Luc) in SCID mice were deter-
mined. Details on this are found in the Supplemental Experimental Procedures.
For basic procedures, see the Supplemental Experimental Procedures.
Statistical Analyses
The data are expressed as the mean ± SD. Significance was assessed using
an independent two-tailed Student’s t test; A p value of less than 0.1 was
considered statistically significant. NS, non-specific. *p < 0.1, **p < 0.01,
***p < 0.005 by Student’s t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2015.10.034
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